USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: E.P., LTD
City: SOMERVILLE
State: MA
Zip+4: 02143
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (617) 623-3157

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $389,542.00 6
SBIR Phase II $4,154,378.00 2

Award List:

COMPARISON OF ADAPTIVE METHODS TO REMOVE MOTION ARTIFACT

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Patrick S. Hamilton
Award Amount: $100,000.00

NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael G. Curley
Award Amount: $89,530.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Patrick S. Hamilton
Award Amount: $100,012.00
Abstract:
Not Available The main motivation for a reconfigurable collision avoidance system is greater survivability, possible if the feedback system can reorganize itself in the presence of obstacles, actuator failures and surface damages. This project develops an autonomous in

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Patrick S. Hamilton
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael G. Curley
Award Amount: $0.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael G. Curley
Award Amount: $475,399.00

NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael G. Curley
Award Amount: $0.00
Abstract:
DESCRIPTION (provided by applicant): Sudden cardiac death kills 300,000 people in the United States yearly. More than half of these deaths are caused by arrhythmias including ventricular tachycardia. Radiofrequency ablation, which successfully treats supraventricular tachycardia, is not successful… More

NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Michael G. Curley
Award Amount: $3,678,979.00
Abstract:
DESCRIPTION (provided by applicant): Ischemic ventricular tachycardia (VT) is a contributing cause to more than half of the 300,000 sudden cardiac deaths that occur annually in the United States. Implantable cardioverter defibrillators (ICDs) are the stand ard therapy but they are expensive the… More